MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 357 filers reported holding MEDIVATION INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $7,718,000 | +34.2% | 128,001 | +2.3% | 0.10% | +25.3% |
| Q1 2016 | $5,753,000 | -13.6% | 125,114 | -9.2% | 0.08% | -2.5% |
| Q4 2015 | $6,660,000 | +20.2% | 137,782 | +5.7% | 0.08% | +3.8% |
| Q3 2015 | $5,541,000 | -27.8% | 130,380 | +94.1% | 0.08% | -26.4% |
| Q2 2015 | $7,671,000 | -11.4% | 67,168 | +0.1% | 0.11% | +3.9% |
| Q1 2015 | $8,660,000 | +56.4% | 67,093 | +20.7% | 0.10% | +59.4% |
| Q4 2014 | $5,537,000 | +31.9% | 55,589 | +30.9% | 0.06% | +14.3% |
| Q3 2014 | $4,198,000 | +9.2% | 42,462 | -14.8% | 0.06% | +12.0% |
| Q2 2014 | $3,843,000 | -2.9% | 49,859 | -18.9% | 0.05% | 0.0% |
| Q1 2014 | $3,959,000 | +73.8% | 61,501 | +72.3% | 0.05% | +47.1% |
| Q4 2013 | $2,278,000 | +32.8% | 35,690 | +24.7% | 0.03% | -17.1% |
| Q3 2013 | $1,715,000 | +112.8% | 28,618 | +74.7% | 0.04% | +156.2% |
| Q2 2013 | $806,000 | – | 16,381 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $186,908,000 | 79.34% |
| Redmile Group, LLC | 1,752,642 | $74,487,000 | 5.64% |
| APIS CAPITAL ADVISORS, LLC | 93,500 | $3,974,000 | 5.50% |
| March Altus Capital Management LP | 18,794 | $799,000 | 4.71% |
| HealthCor Management, L.P. | 1,900,000 | $80,750,000 | 4.55% |
| BB BIOTECH AG | 2,581,112 | $109,697,000 | 3.48% |
| Selkirk Management LLC | 116,000 | $4,930,000 | 3.06% |
| Opus Point Partners Management, LLC | 118,372 | $5,031,000 | 2.78% |
| TORRAY INVESTMENT PARTNERS LLC | 797,015 | $33,873,000 | 2.49% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 3,772,600 | $160,336,000 | 1.78% |